Patients are Sutro’s
passion and purpose.
Sutro is advancing a next-generation antibody-drug conjugate platform designed to deliver single- and dual-payload ADCs that enable meaningful breakthroughs for patients with cancer.
Next Generation Cancer Therapeutics
Science designed to deliver ENDLESS OPPORTUNITY
Enabling a future where more is POSSIBLE.
Sutro’s proprietary technology enables therapeutics that may provide broader patient benefit and an improved patient experience.
INVESTOR RESOURCES
NASDAQ: STRO
Stock Symbol